Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Employees
Cyclo Therapeutics had 8 employees as of December 31, 2023. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
$108,841
Profits / Employee
-$3,099,959
Market Cap
18.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Flora Growth | 108 |
Carisma Therapeutics | 107 |
Senti Biosciences | 48 |
IN8bio | 31 |
Bullfrog AI | 11 |
Alterity Therapeutics | 10 |
CervoMed | 8 |
XTL Biopharmaceuticals | 7 |
CYTH News
- 1 day ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders - PRNewsWire
- 4 weeks ago - Niemann-Pick Disease Pipeline Market Research 2024: Comprehensive Insights about 12+ Drugs Featuring Cyclo Therapeutics, Azafaros, IntraBio - GlobeNewsWire
- 5 weeks ago - Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1) - Business Wire
- 4 months ago - CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH - Business Wire
- 4 months ago - Accession Risk Management Group Closes $1 Billion Financing to Further Accelerate Growth of Risk Strategies and One80 Intermediaries - Business Wire
- 4 months ago - Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement - Business Wire
- 4 months ago - Cyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Business Wire